Clinical Trials Logo

Red Blood Cells clinical trials

View clinical trials related to Red Blood Cells.

Filter by:
  • None
  • Page 1

NCT ID: NCT05380999 Not yet recruiting - Lung Cancer Clinical Trials

The Red Blood Cells Based Blood Test for Lung Cancer EARLY Detection

Start date: May 2022
Phase:
Study type: Observational

This study plan to enroll 852 patients with pulmonary nodules smaller than 3 cm in diameter, whose DNA and RNA will be extracted from mature red blood cells isolated from peripheral blood. The DNA 5-methylcytosine(5-mC) and RNA 2'-O-methylation information will be acquired by NGS and Nm Judge Universally sequencing (NJU-Seq), which will be used to establish models to distinguish patients with benign and malignant nodule in the training group and further evaluated in the validation group. The pathological results will be acquired after surgery or biopsy as standard in the study.

NCT ID: NCT05331235 Not yet recruiting - Preterm Clinical Trials

Blood Transfusions in Preterm Infants

Start date: May 1, 2022
Phase:
Study type: Observational

A cross sectional study to assess the effect of blood transfusions on the outcome of preterm infants

NCT ID: NCT05282888 Recruiting - Clinical trials for Artificial Intelligence

ERYthrocyte Morphology Using Flow Imaging on ImageSTREAM Cytometer

ERYSTREAM
Start date: March 8, 2022
Phase:
Study type: Observational

Erythrocyte morphology analysis is a key step in the diagnosis flowchart of anemia. It is performed on a peripheral blood smear after May Grümwald Giemsa staining. In the context of hemolytic anemias for example, it allows the recognition of therapeutic emergencies such as sickle cell disease crisis, malaria-induced hemolysis and thrombotic microangiopathy, the latter being characterized by the presence of schistocytes and justifying an immediate clinical care. However, cytological analysis of erythrocyte morphology requires pre-analytical interventions (smear spreading + staining), the quality of which determines the accuracy of the result. Moreover, it requires a good cytological expertise and may be sometimes subjective. For several years, alternative methods for erythrocyte morphology evaluation have been developed, based on automated hematology machines or automated microscopy. Nevertheless, none of them has yet proven itself in comparison with cytology, especially in the diagnosis of thrombotic microangiopathies. By combining the advantages of flow cytometry and microscopy, flow imaging appears to be a promising technology for the diagnosis of anemias: it does not require any pre-analytical intervention, does not require any spreading and analyzes a large number of events. Moreover, it can be coupled with artificial intelligence via the generation of an apprenticeship by the constitution of a large image data base, which then allows the recognition of the different red blood cells morphologies without human eyes. The objective of this study is to build a data base containing the main red blood cell morphologies relevant in anemia, and to validate it through a comparison in anemic patients of erythrocyte morphological assessment either directly on whole blood by flow imaging or routinely by cytological analysis of peripheral blood smear after by a trained operator.

NCT ID: NCT02575820 Withdrawn - Clinical trials for Postoperative Complications

Old Blood and Postoperative Complications

Start date: November 2015
Phase: N/A
Study type: Observational

The investigators sought to examine the effects of 'old' red blood cells on mortality and morbidity of patients who undergoing revision hip replacement arthroplasty. The investigators hypothesis is that patients have an increased risk of mortality and infection after 'old' red blood cells transfusions compared with those who received 'new' transfusions.

NCT ID: NCT02265003 Completed - Clinical trials for Endothelial Function

Red Blood Cells as a Reflection of Endothelial Function in Old Age

Start date: July 2012
Phase:
Study type: Observational

The aim of this study is to find out, how far red blood cells reflect age-depended changes in endothelial function.